{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-007620","form_type":"8-K","ticker":"PAYS","cik":"0001496443","company_name":"Paysign, Inc.","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.587839+00:00","generated_at":"2026-05-30T05:18:19.078623+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Paysign Q3 revenue up 23% to $15.26M; pharma affordability revenue surges 219%","bullets":["Total revenues $15.26M (+23% YoY); net income $1.44M ($0.03 diluted EPS) vs $1.10M ($0.02) prior year.","Pharma patient affordability revenue surged 219.1% YoY, now 21.5% of total revenue; 66 active programs at quarter end.","Adjusted EBITDA $2.83M (+20.6% YoY); FY2024 guidance reaffirmed: rev $56.5-58.5M, adj. EBITDA $9-10M.","Plasma revenue up 3.4% YoY from 478 centers; average monthly revenue per center $7,991, down slightly from $8,041.","Unrestricted cash $10.29M, zero debt; Q4 legal expense expected for class action settlement but within guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-007620","json":"https://secwatch.observer/filing/0001683168-24-007620.json","markdown":"https://secwatch.observer/filing/0001683168-24-007620.md","text":"https://secwatch.observer/filing/0001683168-24-007620.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1496443/000168316824007620/0001683168-24-007620-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1496443/000168316824007620/paysign_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:18:19.078623+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}